KPL ApS Launches High-Performance, Sequencing-Grade Lys-C for Superior Proteomics Analysis
COPENHAGEN, Denmark, September 23, 2024 – KPL ApS is proud to announce the launch of our recombinant, sequencing-grade Lysyl endopeptidase (Lys-C), KPL0033. Recombinantly produced in Escherichia coli and optimized for mass spectrometry-based proteomics, our Lys-C is designed to cleave specifically at the C-terminus of Lysine residues, setting a new standard for enzyme performance.
Superior Performance in Proteomics
Originally identified in Achromobacter lyticus, our Lys-C offers unmatched accuracy, minimizing missed cleavages and maximizing peptide integrity in your workflows.
Key Benefits of Lys-C KPL0033
The advantages of our Lys-C’s low missed cleavage rate is significant. Researchers can expect:
- Higher Number of Peptide Identifications: The signal isn’t split between fully cleaved and partially cleaved peptides, leading to stronger signal strength.
- Improved Detection Sensitivity: This leads to more comprehensive proteome coverage.
- Superior Data Quality: Enhanced reproducibility and accuracy across experiments ensure precise data, pushing the boundaries of proteomics discovery.
Scientists can now quite literally “cleave through the noise,” ensuring more precise data and pushing the boundaries of proteomics discovery.
Learn More and Order
To learn more and order Lys-C KPL0033, visit lysc.bio and bring reliability to your proteomics research.